Biblio

Found 7 results
Filters: Keyword is Tumor Cells, Cultured  [Clear All Filters]
2017
Keresztes A, Streicher JM.  2017.  Synergistic interaction of the cannabinoid and death receptor systems - a potential target for future cancer therapies? FEBS Lett. 591(20):3235-3251.
2006
Ignatenko NA, Yerushalmi HF, Watts GS, Futscher BW, Stringer DE, Marton LJ, Gerner EW.  2006.  Pharmacogenomics of the polyamine analog 3,8,13,18-tetraaza-10,11-[(E)-1,2-cyclopropyl]eicosane tetrahydrochloride, CGC-11093, in the colon adenocarcinoma cell line HCT1161.. Technol Cancer Res Treat. 5(6):553-64.
2003
Oshiro MM, Watts GS, Wozniak RJ, Junk DJ, Munoz-Rodriguez JL, Domann FE, Futscher BW.  2003.  Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression.. Oncogene. 22(23):3624-34.
2002
Crowley-Weber CL, Payne CM, Gleason-Guzman M, Watts GS, Futscher B, Waltmire CN, Crowley C, Dvorakova K, Bernstein C, Craven M et al..  2002.  Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate.. Carcinogenesis. 23(12):2063-80.
2001
Watts GS, Futscher BW, Isett R, Gleason-Guzman M, Kunkel MW, Salmon SE.  2001.  cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways.. J Pharmacol Exp Ther. 299(2):434-41.
Calaluce R, Kunkel MW, Watts GS, Schmelz M, Hao J, Barrera J, Gleason-Guzman M, Isett R, Fitchmun M, Bowden GT et al..  2001.  Laminin-5-mediated gene expression in human prostate carcinoma cells.. Mol Carcinog. 30(2):119-29.
1995
Watts GS, Futscher BW.  1995.  Detecting differences in 5-methylcytosine using restriction enzyme isoschizomers: an endogenous control for complete digestion.. Nucleic Acids Res. 23(22):4740-1.